Shanghai, China – On December 31, Hercules™ Stent Graft and Delivery System, in-house developed by MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular"), was awarded 2016 Shanghai Top-Brand Product, according to a list released by Shanghai Top Brand Recommendation Committee of Shanghai Municipal Bureau of Quality and Technical Supervision. The award is to honor well-known products and brands with industry-leading position, high customer satisfaction and great development potential.

Shanghai Top-Brand Products are selected by Shanghai Top Brand Recommendation Committee of Shanghai Municipal Bureau of Quality and Technical Supervision, based on the company's core competitiveness, industry position, strategy of building independent brands, innovation sustainability, R&D input, innovative development strategy, as well as the role it plays in driving the industry development. This honorable title signifies government recognition in the brand image of Hercules® Stent Graft and Delivery System as well as the overall performance of MicroPort® Endovascular.

Hercules™ Stent Graft and Delivery System is one of the core products in-house developed by MicroPort® Endovascular. Hercules™ products align with China and Shanghai's development policies of the bioengineering and pharmaceutical industry, and were listed as Shanghai's first batch of independently innovated products. Hercules™ products include Hercules™ Thoracic Aortic Aneurysm Stent Graft and Delivery System and Hercules™ Abdominal Aortic Aneurysm Stent Graft and Delivery System, both are first of its kind in China, respectively designed for the treatment of thoracic aortic aneurysm and abdominal aortic aneurysm. Since market launch, Hercules™ products demonstrated outstanding clinical performance and have saved around 30,000 patients with aortic diseases.